(Total Views: 505)
Posted On: 05/20/2025 12:21:25 PM
Post# of 155737
Measuring PD-L1 was a trial Measurement.
The addtional trials were/are a backlog based on mTNBC / PD-L1 outcome.
& why, because they intend to foundation off Oncology & Inflammation. The two that are most going on around us.
Once mTNBC PD-L1 is confirmed, @ any day now, that is 100% partnership quality. Also tons of other funding, grants & etc..
Then CRC will have started & when Interim Safety shows excellent trend, watch out. FOMO turns sustained because --- we have those other trials also kicking into gear.
The past will have teamed with the future.
The addtional trials were/are a backlog based on mTNBC / PD-L1 outcome.
& why, because they intend to foundation off Oncology & Inflammation. The two that are most going on around us.
Once mTNBC PD-L1 is confirmed, @ any day now, that is 100% partnership quality. Also tons of other funding, grants & etc..
Then CRC will have started & when Interim Safety shows excellent trend, watch out. FOMO turns sustained because --- we have those other trials also kicking into gear.
The past will have teamed with the future.
(5)
(0)
